Debt-to-equity of CUMBERLAND PHARMACEUTICALS INC from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
CUMBERLAND PHARMACEUTICALS INC quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • CUMBERLAND PHARMACEUTICALS INC Debt-to-equity for the quarter ending 30 Sep 2025 was 166%, a 15% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

CUMBERLAND PHARMACEUTICALS INC Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 166% -30% -15% 30 Sep 2025
Q2 2025 179% +2% +1.4% 30 Jun 2025
Q1 2025 194% +32% +20% 31 Mar 2025
Q4 2024 209% +58% +38% 31 Dec 2024
Q3 2024 196% +48% +33% 30 Sep 2024
Q2 2024 177% +32% +22% 30 Jun 2024
Q1 2024 162% +19% +13% 31 Mar 2024
Q4 2023 151% +11% +7.8% 31 Dec 2023
Q3 2023 147% +22% +18% 30 Sep 2023
Q2 2023 145% +32% +28% 30 Jun 2023
Q1 2023 143% +43% +42% 31 Mar 2023
Q4 2022 140% +48% +52% 31 Dec 2022
Q3 2022 125% +31% +33% 30 Sep 2022
Q2 2022 113% +15% +16% 30 Jun 2022
Q1 2022 101% -1% -0.9% 31 Mar 2022
Q4 2021 92% -8% -8.3% 31 Dec 2021
Q3 2021 94% -6% -6.1% 30 Sep 2021
Q2 2021 98% -3% -2.9% 30 Jun 2021
Q1 2021 102% +1% +1.5% 31 Mar 2021
Q4 2020 101% -2% -2.4% 31 Dec 2020
Q3 2020 100% -2% -2% 30 Sep 2020
Q2 2020 100% +11% +12% 30 Jun 2020
Q1 2020 100% +23% +30% 31 Mar 2020
Q4 2019 103% +40% +64% 31 Dec 2019
Q3 2019 102% +53% +108% 30 Sep 2019
Q2 2019 89% +43% +93% 30 Jun 2019
Q1 2019 77% +36% +86% 31 Mar 2019
Q4 2018 63% +27% +76% 31 Dec 2018
Q3 2018 49% +18% +58% 30 Sep 2018
Q2 2018 46% +19% +70% 30 Jun 2018
Q1 2018 41% +18% +74% 31 Mar 2018
Q4 2017 36% +14% +65% 31 Dec 2017
Q3 2017 31% +12% +59% 30 Sep 2017
Q2 2017 27% +8% +45% 30 Jun 2017
Q1 2017 24% +5% +27% 31 Mar 2017
Q4 2016 22% +3% +19% 31 Dec 2016
Q3 2016 20% +2% +11% 30 Sep 2016
Q2 2016 19% +2% +9.5% 30 Jun 2016
Q1 2016 19% +2% +13% 31 Mar 2016
Q4 2015 18% +2% +11% 31 Dec 2015
Q3 2015 18% +3% +23% 30 Sep 2015
Q2 2015 17% +3% +24% 30 Jun 2015
Q1 2015 17% +3% +21% 31 Mar 2015
Q4 2014 16% +3% +19% 31 Dec 2014
Q3 2014 14% 0% -3.1% 30 Sep 2014
Q2 2014 14% -2% -11% 30 Jun 2014
Q1 2014 14% -2% -11% 31 Mar 2014
Q4 2013 14% -2% -11% 31 Dec 2013
Q3 2013 15% -1% -3.6% 30 Sep 2013
Q2 2013 16% 0% +2.8% 30 Jun 2013
Q1 2013 15% 0% -0.64% 31 Mar 2013
Q4 2012 15% 31 Dec 2012
Q3 2012 15% 30 Sep 2012
Q2 2012 15% 30 Jun 2012
Q1 2012 16% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.